RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Legier V. Rojas to Bungarotoxins

This is a "connection" page, showing publications Legier V. Rojas has written about Bungarotoxins.
Connection Strength

0.060
  1. Guzm?n GR, Ortiz-Acevedo A, Ricardo A, Rojas LV, Lasalde-Dominicci JA. The polarity of lipid-exposed residues contributes to the functional differences between Torpedo and muscle-type nicotinic receptors. J Membr Biol. 2006; 214(3):131-8.
    View in: PubMed
    Score: 0.019
  2. Navedo M, Nieves M, Rojas L, Lasalde-Dominicci JA. Tryptophan substitutions reveal the role of nicotinic acetylcholine receptor alpha-TM3 domain in channel gating: differences between Torpedo and muscle-type AChR. Biochemistry. 2004 Jan 13; 43(1):78-84.
    View in: PubMed
    Score: 0.015
  3. Guzm?n GR, Santiago J, Ricardo A, Mart?-Arbona R, Rojas LV, Lasalde-Dominicci JA. Tryptophan scanning mutagenesis in the alphaM3 transmembrane domain of the Torpedo californica acetylcholine receptor: functional and structural implications. Biochemistry. 2003 Oct 28; 42(42):12243-50.
    View in: PubMed
    Score: 0.015
  4. Tamamizu S, Guzm?n GR, Santiago J, Rojas LV, McNamee MG, Lasalde-Dominicci JA. Functional effects of periodic tryptophan substitutions in the alpha M4 transmembrane domain of the Torpedo californica nicotinic acetylcholine receptor. Biochemistry. 2000 Apr 25; 39(16):4666-73.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support